Arkolith/Insider Trading/VRDN/Form 4

Violin Jonathan

Chief Executive Officer, DirectorViridian Therapeutics, Inc.\DE (VRDN) · full profile →Form 4 · filed Feb 3, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.8M
Net Open-Market Flow
-$1.8M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 2, 2023Sell(S)50K$36.80$1.8M431K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-003921) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML